|
Vol. 9, Issue 3, 215-225, March 1999
The Sox10Dom Mouse: Modeling the Genetic Variation of Waardenburg-Shah (WS4) Syndrome
E. Michelle
Southard-Smith,1
Misha
Angrist,2
Jane S.
Ellison,1
Richa
Agarwala,1
Andreas D.
Baxevanis,3
Aravinda
Chakravarti,2 and
William J.
Pavan1,4
1 Genetic Disease Research Branch, National Human Genome
Research Institute, National Institutes of Health (NIH), Bethesda,
Maryland 20892-4472 USA; 2 Department of Genetics and Center
for Human Genetics, Case Western Reserve University and University
Hospitals of Cleveland, Cleveland, Ohio 44106-4955 USA;
3 Genome Technology Branch, National Human Genome Research
Institute, National Institutes of Health,
Bethesda, Maryland 20892-4431 USA
Hirschsprung disease (HSCR) is a multigenic neurocristopathy
clinically recognized by aganglionosis of the distal gastrointestinal tract. Patients presenting with aganglionosis in association with hypopigmentation are classified as Waardenburg syndrome type 4 (Waardenburg-Shah, WS4). Variability in the disease phenotype of WS4
patients with equivalent mutations suggests the influence of genetic
modifier loci in this disorder. Sox10Dom/+ mice
exhibit variability of aganglionosis and hypopigmentation influenced by
genetic background similar to that observed in WS4 patients. We have
constructed Sox10Dom/+ congenic lines to segregate
loci that modify the neural crest defects in these mice. Consistent
with previous studies, increased lethality of
Sox10Dom/+ animals resulted from a C57BL/6J
locus(i). However, we also observed an increase in hypopigmentation in
conjunction with a C3HeB/FeJLe-a/a locus(i). Linkage analysis localized
a hypopigmentation modifier of the Dom phenotype to mouse
chromosome 10 in close proximity to a previously reported modifier of
hypopigmentation for the endothelin receptor B mouse model of WS4. To
evaluate further the role of SOX10 in development and disease,
we have performed comparative genomic analyses. An essential role for this gene in neural crest development is supported by zoo blot hybridizations that reveal extensive conservation throughout vertebrate evolution and by similar Northern blot expression profiles between mouse and man. Comparative sequence analysis of the mouse and human
SOX10 gene have defined the exon-intron boundaries of
SOX10 and facilitated mutation analysis leading to the
identification of two new SOX10 mutations in individuals with WS4.
Structural analysis of the HMG DNA-binding domain was performed to
evaluate the effect of human mutations in this region.
4
Corresponding author.
9:215-225 ©1999 by Cold Spring Harbor Laboratory Press ISSN 1088-9051/99 $5.00

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
I. Matera, D. E. Watkins-Chow, S. K. Loftus, L. Hou, A. Incao, D. L. Silver, C. Rivas, E. C. Elliott, L. L. Baxter, and W. J. Pavan
A sensitized mutagenesis screen identifies Gli3 as a modifier of Sox10 neurocristopathy
Hum. Mol. Genet.,
July 15, 2008;
17(14):
2118 - 2131.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J Amiel, E Sproat-Emison, M Garcia-Barcelo, F Lantieri, G Burzynski, S Borrego, A Pelet, S Arnold, X Miao, P Griseri, et al.
Hirschsprung disease, associated syndromes and genetics: a review
J. Med. Genet.,
January 1, 2008;
45(1):
1 - 14.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. E. Owens, K. W. Broman, T. Wiltshire, J. B. Elmore, K. M. Bradley, J. R. Smith, and E. M. Southard-Smith
Genome-wide linkage identifies novel modifier loci of aganglionosis in the Sox10Dom model of Hirschsprung disease
Hum. Mol. Genet.,
June 1, 2005;
14(11):
1549 - 1558.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. A. Cantrell, S. E. Owens, R. L. Chandler, D. C. Airey, K. M. Bradley, J. R. Smith, and E. M. Southard-Smith
Interactions between Sox10 and EdnrB modulate penetrance and severity of aganglionosis in the Sox10Dom mouse model of Hirschsprung disease
Hum. Mol. Genet.,
October 1, 2004;
13(19):
2289 - 2301.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. S. McCallion, E. Stames, R. A. Conlon, and A. Chakravarti
Phenotype variation in two-locus mouse models of Hirschsprung disease: Tissue-specific interaction between Ret and Ednrb
PNAS,
February 18, 2003;
100(4):
1826 - 1831.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. C. Stolt, S. Rehberg, M. Ader, P. Lommes, D. Riethmacher, M. Schachner, U. Bartsch, and M. Wegner
Terminal differentiation of myelin-forming oligodendrocytes depends on the transcription factor Sox10
Genes & Dev.,
January 15, 2002;
16(2):
165 - 170.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Bondurand, M. Girard, V. Pingault, N. Lemort, O. Dubourg, and M. Goossens
Human Connexin 32, a gap junction protein altered in the X-linked form of Charcot-Marie-Tooth disease, is directly regulated by the transcription factor SOX10
Hum. Mol. Genet.,
November 1, 2001;
10(24):
2783 - 2795.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. A. Dutton, A. Pauliny, S. S. Lopes, S. Elworthy, T. J. Carney, J. Rauch, R. Geisler, P. Haffter, and R. N. Kelsh
Zebrafish colourless encodes sox10 and specifies non-ectomesenchymal neural crest fates
Development,
November 1, 2001;
128(21):
4113 - 4125.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Amiel and S. Lyonnet
Hirschsprung disease, associated syndromes, and genetics: a review
J. Med. Genet.,
November 1, 2001;
38(11):
729 - 739.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Sock, K. Schmidt, I. Hermanns-Borgmeyer, M. R. Bosl, and M. Wegner
Idiopathic Weight Reduction in Mice Deficient in the High-Mobility-Group Transcription Factor Sox8
Mol. Cell. Biol.,
October 15, 2001;
21(20):
6951 - 6959.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Paratore, D. E. Goerich, U. Suter, M. Wegner, and L. Sommer
Survival and glial fate acquisition of neural crest cells are regulated by an interplay between the transcription factor Sox10 and extrinsic combinatorial signaling
Development,
October 15, 2001;
128(20):
3949 - 3961.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. H. Sham, V. C. H. Lui, B. L. S. Chen, M. Fu, and P. K. H. Tam
Novel mutations of SOX10 suggest a dominant negative role in Waardenburg-Shah syndrome
J. Med. Genet.,
September 1, 2001;
38(9):
e30 - 30.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M H Sham, V C H Lui, M Fu, B Chen, and P K H Tam
SOX10 is abnormally expressed in aganglionic bowel of Hirschsprung's disease infants
Gut,
August 1, 2001;
49(2):
220 - 226.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Britsch, D. E. Goerich, D. Riethmacher, R. I. Peirano, M. Rossner, K.-A. Nave, C. Birchmeier, and M. Wegner
The transcription factor Sox10 is a key regulator of peripheral glial development
Genes & Dev.,
January 1, 2001;
15(1):
66 - 78.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
R. I. Peirano and M. Wegner
The glial transcription factor Sox10 binds to DNA both as monomer and dimer with different functional consequences
Nucleic Acids Res.,
August 15, 2000;
28(16):
3047 - 3055.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Bondurand, V. Pingault, D. E. Goerich, N. Lemort, E. Sock, C. L. Caignec, M. Wegner, and M. Goossens
Interaction among SOX10, PAX3 and MITF, three genes altered in Waardenburg syndrome
Hum. Mol. Genet.,
August 12, 2000;
9(13):
1907 - 1917.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. I. Peirano, D. E. Goerich, D. Riethmacher, and M. Wegner
Protein Zero Gene Expression Is Regulated by the Glial Transcription Factor Sox10
Mol. Cell. Biol.,
May 1, 2000;
20(9):
3198 - 3209.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
Y Wakamatsu, T. Maynard, and J. Weston
Fate determination of neural crest cells by NOTCH-mediated lateral inhibition and asymmetrical cell division during gangliogenesis
Development,
January 7, 2000;
127(13):
2811 - 2821.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Bolk, A. Pelet, R. M. W. Hofstra, M. Angrist, R. Salomon, D. Croaker, C. H. C. M. Buys, S. Lyonnet, and A. Chakravarti
A human model for multigenic inheritance: Phenotypic expression in Hirschsprung disease requires both the RET gene and a new 9q31 locus
PNAS,
January 4, 2000;
97(1):
268 - 273.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Rhim, K. J. Dunn, A. Aronzon, S. Mac, M. Cheng, M. L. Lamoreux, S. M. Tilghman, and W. J. Pavan
Spatially Restricted Hypopigmentation Associated with an Ednrbs-Modifying Locus on Mouse Chromosome 10
Genome Res.,
January 1, 2000;
10(1):
17 - 29.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
N. Bondurand, K. Kuhlbrodt, V. Pingault, J. Enderich, M. Sajus, N. Tommerup, M. Warburg, R. C. M. Hennekam, A. P. Read, M. Wegner, et al.
A molecular analysis of the Yemenite deaf-blind hypopigmentation syndrome: SOX10 dysfunction causes different neurocristopathies
Hum. Mol. Genet.,
September 1, 1999;
8(9):
1785 - 1789.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|